🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted action to tackle cost of living pressures" in the forthcoming financial statement.

Speaking to media outlets, she stated that curbing price rises is a shared duty of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the G7 developed nations this year and the following year.

Possible Energy Bill Interventions

It is understood the administration could intervene to lower energy bills, for instance by cutting the current 5% level of value-added tax applied on energy.

An additional possibility is to cut some of the government charges presently included in household expenses.

Fiscal Limitations and Analyst Expectations

The administration will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much space there is for these measures.

The view from the majority of economists is that Reeves will have to announce higher taxes or expenditure reductions in order to meet her self-imposed fiscal targets.

Previously on Thursday, analysis showed there was a twenty-two billion pound deficit for the chancellor to fill, which is at the lower end of forecasts.

"It is a joint job between the central bank and the government to further reduce some of the causes of inflation," Reeves told the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While a great deal of the focus has been on likely tax increases, the chancellor said the latest data from the OBR had not changed her pledge to manifesto promises not to increase tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with increasing international and commercial issues for the fiscal tax moves, probably to be targeted on those "with the broadest shoulders."

International Trade Disputes

Referring to concerns about the UK's economic relations with the Asian nation she said: "Our security interests always are paramount."

Recent declaration by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are essential for high-technology production led US President Donald Trump to threaten an additional 100% tariff on imports from China, raising the prospect of an all-out commercial conflict between the two economic giants.

The American finance chief described the Chinese decision "commercial pressure" and "a global supply chain power grab."

Asked about considering the US offer to participate in its dispute with the Asian nation, Reeves said she was "very concerned" by China's measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the international commerce and creates additional obstacles."

"In my view there are areas where we should challenge China, but there are also significant chances to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance appropriate."

The Treasury chief also affirmed she was collaborating with other major economies "regarding our own essential resources plan, so that we are reduced dependence."

NHS Medicine Pricing and Funding

Reeves also admitted that the price the NHS pays for medicines could go up as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping operations in the United Kingdom, with several blaming the modest returns they are getting.

Last month, the government science advisor said the price the health service spends on drugs would need to increase to prevent firms and drug research funding leaving the United Kingdom.

Reeves stated to the BBC: "We have seen due to the cost structure, that clinical trials, innovative medicines have not been offered in the UK in the way that they are in other European countries."

"We want to guarantee that individuals receiving care from the National Health Service are can access the top critical treatments in the globe. And so we are looking at this situation, and... seeking to secure increased capital into Britain."